These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 12564742

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 23. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 24. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
    Herpin D, Guillard O, Piriou A, Amiel A, Boutaud P, Ciber MA, Demange J.
    Ann Med Interne (Paris); 1988 Mar; 139(7):484-7. PubMed ID: 3072894
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 26. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.
    Clamp M, Holmes B, Wilcox R.
    J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646
    [Abstract] [Full Text] [Related]

  • 27. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG.
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [Abstract] [Full Text] [Related]

  • 28. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Dec; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 31. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R, Andreoni A, Saccomanno G, Gambini C, Paciaroni E.
    Drugs Exp Clin Res; 1989 Nov; 15(11-12):577-81. PubMed ID: 2700320
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F, Ciriello G.
    Adv Ther; 1995 Nov; 12(4):212-21. PubMed ID: 10155349
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F, Trimarco B, Petretta M, Ferrara N, Bonaduce D, Chiariello M, Condorelli M.
    G Ital Cardiol; 1978 Nov; 8(8):861-7. PubMed ID: 359398
    [Abstract] [Full Text] [Related]

  • 39. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG, Ostroumova OD, Mamaev VI, Batutina AM, Abakumov IuE, Zykova AA.
    Ter Arkh; 2003 Nov; 75(8):43-7. PubMed ID: 14520850
    [Abstract] [Full Text] [Related]

  • 40. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
    Giesecke HG, Buchner-Möll D.
    J Cardiovasc Pharmacol; 1990 Nov; 16 Suppl 5():S175-8. PubMed ID: 11527123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.